Y-mAbs Therapeutics Inc Sustainability Reports
A biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00J2DBN04
1 reports from 2024 to 2024